Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) — Cash Flow Reinvestment Rate
Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥105.16 Million (capex CN¥105.16 Million ) from operating cash flow of CN¥504.02 Million. Explore 002773 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Chengdu Kanghong Pharmaceuticals Group Co Ltd across 17 annual periods. Also explore how large is Chengdu Kanghong Pharmaceuticals Group C's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for Chengdu Kanghong Pharmaceuticals Group Co Ltd. For live market cap and broader valuation context, see Chengdu Kanghong Pharmaceuticals Group C market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | CN¥299.36 Million | CN¥1.50 Billion | CN¥262.48 Million | ▲ +35.7% |
| 2024 | 0.15x | CN¥207.10 Million | CN¥1.41 Billion | CN¥159.39 Million | ▲ +22.8% |
| 2023 | 0.12x | CN¥145.49 Million | CN¥1.22 Billion | CN¥138.87 Million | ▼ -80.6% |
| 2022 | 0.62x | CN¥570.76 Million | CN¥925.15 Million | CN¥355.21 Million | ▼ -62.9% |
| 2021 | 1.66x | CN¥821.27 Million | CN¥494.11 Million | CN¥569.42 Million | ▼ -27.6% |
| 2020 | 2.29x | CN¥627.07 Million | CN¥273.32 Million | CN¥617.07 Million | ▲ +66.5% |
| 2019 | 1.38x | CN¥1.12 Billion | CN¥812.15 Million | CN¥962.88 Million | ▼ -28.9% |
| 2018 | 1.94x | CN¥680.45 Million | CN¥350.88 Million | CN¥458.45 Million | ▲ +159.6% |
| 2017 | 0.75x | CN¥572.88 Million | CN¥766.86 Million | CN¥312.88 Million | ▲ +50.4% |
| 2016 | 0.50x | CN¥420.39 Million | CN¥846.35 Million | CN¥170.23 Million | ▼ -16.9% |
| 2015 | 0.60x | CN¥288.04 Million | CN¥481.97 Million | CN¥115.83 Million | ▲ +92.9% |
| 2014 | 0.31x | CN¥90.27 Million | CN¥291.38 Million | CN¥90.27 Million | ▲ +33.8% |
| 2013 | 0.23x | CN¥77.16 Million | CN¥333.31 Million | CN¥77.16 Million | ▼ -49.6% |
| 2012 | 0.46x | CN¥129.51 Million | CN¥281.84 Million | CN¥129.51 Million | ▼ -50.7% |
| 2011 | 0.93x | CN¥157.25 Million | CN¥168.86 Million | CN¥157.25 Million | ▼ -3.3% |
| 2010 | 0.96x | CN¥131.76 Million | CN¥136.79 Million | CN¥131.76 Million | ▼ -34.0% |
| 2009 | 1.46x | CN¥158.27 Million | CN¥108.42 Million | CN¥158.27 Million | — |